Pricing Log in Create free account

IMMURON (IMRN) vs Soligenix Inc. (SNGX)

IMMURON and Soligenix Inc. are both Biotechnology companies. IMMURON and Soligenix Inc. are of similar size ($7.3M and $6.9M). IMMURON grew revenue faster over the last twelve months: −6.62% against −50.4%. Soligenix Inc. has the higher net margin (0.00% vs −262.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, IMMURON leads on 8 and Soligenix Inc. on 5.

Valuation

Metric IMRN SNGX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 10.97 9.40
P/B n/m 0.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.93 0.18 0.66
EV/Sales (3.47) (4.05) 9.02
Earnings yield (2.51%) (372.59%) (32.88%)
Free cash flow yield 0.00% (179.73%) (23.13%)

Profitability

Metric IMRN SNGX Biotechnology median
Gross margin 71.28% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (262.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (241.65%) (51.96%)
Return on assets 0.00% (125.95%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMRN SNGX Biotechnology median
Revenue growth (TTM) (6.62%) (50.37%) 6.76%
EPS growth (last fiscal year) 37.29% 57.03% 29.88%
Revenue growth, 5-year CAGR 116.96% (51.88%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMRN SNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.26 2.77 4.97
Net debt to EBITDA 1.81 0.67 1.01

Dividend

Metric IMRN SNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMRN SNGX Biotechnology median
Market cap 6.86m 7.26m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack